Ph.D., 2005, University at Albany, State University of New York, Clinical Psychology (APA Accredited)
Pre-doctoral Internship, 2004, University Rochester School of Medicine, Child & Adolescent Clinical Psychology (APA Accredited)
M.A., 2002, University at Albany, State University of New York, Clinical Psychology
B.A., 2000, Plattsburgh State University, State University of New York, Psychology
Scott Weaver is a research associate professor of Population Health Sciences in the School of Public Health at Georgia State University. Prior to coming to Georgia State University, he completed a NRSA postdoctoral fellowship in Prevention Science and Quantitative Methodology at Arizona State University’s Prevention Research Center (2005-2007).
Identifying primarily as a prevention scientist and quantitative methodologist, Dr. Weaver has over a decade of experience conducting research on topics spanning tobacco control and regulatory science; minority and immigrant health and health disparities; substance use and risky youth behaviors; social and cultural determinants of health; systems interventions for promoting positive youth and family outcomes; and global urban health. He has been particularly interested in studying the complex, dynamic systems that interact not only to generate, but also entrench health disparities from a systems perspective. He has developed expertise in various research and statistical methodologies, including latent variable and psychometric models, complex survey analysis, causal inference, analysis of longitudinal data, latent population heterogeneity, and systems science methodologies.
Dr. Weaver’s recent and current research projects have been funded by the FDA, NIH, and WHO. Since 2008, he has been co-PI of an ongoing project to study the structures and process of a network of community systems aimed at improving child and family health and educational outcomes through systems changes and collaborative action. From 2010 – 2015, he was a co-investigator and the director of data and research services for the NIHMD-funded Center of Excellence for Health Disparities (PI: Dr. Michael Eriksen). He has also been PI and co-investigator of multiple projects funded by the WHO to develop urban health metrics for measuring intra- and inter-urban disparities in population health and health determinants. Over the past six years, his research has been focused on perceptions and use of novel and alternative tobacco products, particularly e-cigarettes and little cigars/cigarillos, and the role perceptions have in the decisions to use tobacco products and the implications for tobacco regulatory action and science. He is a co-investigator and lead researcher for the FDA/NIH-funded GSU Tobacco Center of Regulatory Science (PI: Dr. Michael Eriksen), co-investigator for a FDA/NIH-funded R01 to study consumer modification and non-intended use of electronic nicotine delivery systems (ENDS) (PIs: Popova & Ashley), and is PI on an FDA/NIH-funded R03 to examine the impact of e-cigarette warning statements and flavors on youth and young adult perceptions and demand for (ENDS).
Dr. Weaver is a faculty affiliate of the Partnership for Urban Health Research and the Asian Studies Center at Georgia State University and holds an Honorary Senior Research Fellow appointment with the Centre for Epidemiology within the Faculty of Medical and Human Sciences at the University of Manchester.